investor_presentation
KBC Group
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Investor presentation for Onvansertib, a precision medicine therapeutic candidate, highlighting the company's management team and clinical development strategy. The deck outlines the company's approach to turning the tide on cancer through novel drug development and biomarker technology expertise.
investor_presentation
40 Pages
American Water Works Company
investor_presentation
KBC Group
TCS Investor Presentation 2021
investor_presentationinvestor_presentation
29 Pages
Tata Consultancy Services